Structure and functional analyses of vaccinia virus J5 protein reveal distinct determinants for entry-fusion complex assembly and activation

⚕️

This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

Imagine the Vaccinia virus (the virus used in the smallpox vaccine) as a tiny, high-tech submarine trying to invade a city (your body's cells). To get inside, it doesn't just bump into the door; it needs a specialized, multi-part key called the Entry-Fusion Complex (EFC). This key is made of 11 different metal pieces that must lock together perfectly to unlock the cell's membrane and let the virus in.

One of the most critical pieces of this key is a small component called J5. Think of J5 as the "master switch" or the "trigger" on the key. If J5 is broken, the key might look fine, but it won't actually turn the lock.

In this study, scientists decided to take J5 apart to see exactly how it works. Here is what they found, explained simply:

1. Taking a 3D Snapshot (The NMR Structure)

First, the scientists needed to see what J5 looks like in 3D. They used a powerful technique called NMR spectroscopy (think of it like a super-advanced MRI scanner for tiny proteins) to build a digital model of the J5 piece.

They discovered that J5 isn't a messy blob; it's a neat, folded structure made of six little spirals (like coiled springs) held together by three strong "safety pins" (disulfide bonds). This shape is crucial because it allows J5 to snap into place with the other 10 pieces of the key.

2. The Two Critical Zones

The researchers then started playing "spot the difference." They created thousands of tiny viruses where they swapped out or broke specific parts of the J5 piece. They found that J5 has two very different jobs, controlled by two different zones:

Zone A: The "Assembly Glue" (Residues 90-110)

The Analogy: Imagine J5 is a Lego brick. This specific zone is the studs on the bottom of the brick.
What happens if it's broken: If you break these studs, the brick (J5) can't snap onto the other Legos (the rest of the EFC). The whole key falls apart before it even gets to the door.
The Result: The virus can't build its entry key at all. It's like trying to drive a car with no engine; the car looks fine, but it won't move.

Zone B: The "Ignition Switch" (The P38YYCWY43 Motif)

The Analogy: This is the ignition key inside the car.
What happens if it's broken: Surprisingly, if you break this part, the car still assembles perfectly! The engine is built, the wheels are on, and the key is fully formed. However, when you try to start the car, nothing happens. The engine won't turn over.
The Result: The virus builds a perfect entry key, but it's "dead." It can attach to the cell, but it cannot trigger the chemical reaction needed to fuse with the cell membrane and get inside.

3. The "Secret Handshake"

The scientists also found that the "Ignition Switch" zone (Zone B) talks to other parts of the key using a special chemical handshake (called pi-pi stacking). It's like a secret code that tells the key, "Okay, the time is right, now open the door!" When the virus gets close to the cell, this code gets triggered, and the membrane fuses.

Why Does This Matter?

For a long time, scientists knew the Vaccinia virus used this complex key, but they didn't know how the pieces fit together or which parts actually did the work.

This study is like finding the instruction manual for a complex lock. By identifying exactly which parts are for building the key and which parts are for activating it, scientists can now:

Understand how the virus works in much greater detail.
Design better antiviral drugs. Instead of trying to stop the whole virus, we could design a "super-glue" that jams the ignition switch, or a "plastic stud" that prevents the key from assembling. This would stop the virus in its tracks without harming the human cell.

In a nutshell: The J5 protein is a two-in-one tool. One end holds the key together, and the other end actually turns the lock. If you break the holding part, the key falls apart. If you break the turning part, the key is built but useless. Understanding this difference helps us figure out how to stop the virus from entering our cells.

1. Problem Statement

Vaccinia virus (VACV), a prototypic poxvirus, enters host cells via a unique, multi-component Entry-Fusion Complex (EFC) consisting of 11 proteins. Unlike most viruses that rely on a single fusion protein, the VACV EFC utilizes a coordinated machinery where the specific roles of individual components remain poorly defined.

The Gap: While the cryo-EM structure of the full EFC has been recently solved, the specific structural determinants within the J5 protein (a central component of the A16/G9/J5 trimer) that govern EFC assembly versus membrane fusion activation are unclear.
Objective: To define the structural and functional architecture of the J5 ectodomain, identifying which residues are critical for assembling the complex and which are required for triggering membrane fusion.

2. Methodology

The study employed a multidisciplinary approach combining structural biology, bioinformatics, virology, and cell biology:

Protein Expression & Purification: A truncated, soluble ectodomain of VACV J5 (residues 2–68, termed tJ5) was expressed in E. coli with a His₆-SUMO tag, purified via Ni-NTA affinity chromatography, and cleaved to obtain the untagged protein.
NMR Spectroscopy & Structure Determination:
- Uniformly $^{15}$ N/ $^{13}$ C-labeled tJ5 was used for solution NMR experiments (HSQC, NOESY, etc.) at 298 K.
- Backbone resonance assignments were obtained, and NOE-derived distance restraints were used to calculate the 3D structure using XPLOR-NIH and AMBER force fields.
- The final ensemble of 10 structures was validated and deposited (PDB: 8WT5).
Bioinformatics & Modeling:
- Multiple sequence alignments of J5 orthologs from 28 poxvirus species were performed.
- AlphaFold2 was used to predict the structures of chimeric "swap" mutants (replacing VACV J5 sequences with those from Amsacta moorei entomopoxvirus, AMV232).
Viral Engineering:
- Recombinant VACV viruses were generated via homologous recombination in CV-1 cells using a gpt selection cassette.
- Mutants included:
  - Point mutations: Targeting conserved motifs (e.g., P38YYCWY43) and surface residues.
  - Swap mutants (SW): Replacing specific loop/helix regions (e.g., SW(11-18), SW(90-110)) with AMV232 sequences.
Functional Assays:
- Infectivity: Plaque assays on BSC40 cells to measure viral yield.
- Fusion-from-without: HeLa cells expressing GFP/RFP were infected with mutant viruses and treated with acidic buffer (pH 5.0) to trigger membrane fusion. Fusion efficiency was quantified via fluorescence microscopy.
- Co-immunoprecipitation (Co-IP): To assess EFC assembly, lysates from infected cells were immunoprecipitated with antibodies against J5, G9, or A28, followed by immunoblotting for other EFC components.
- Transmission Electron Microscopy (TEM): To verify virion morphogenesis.

3. Key Results

A. Structural Characterization of tJ5

The NMR structure of tJ5 (residues 2–68) revealed a compact fold consisting of six $\alpha$ -helices ( $\alpha$ 1– $\alpha$ 6) stabilized by three intramolecular disulfide bonds (C10-C19, C21-C46, C41-C64).
The structure forms a triangular ring ( $\alpha$ 1, $\alpha$ 3, $\alpha$ 6) with a concave surface formed by outward-projecting helices ( $\alpha$ 2, $\alpha$ 4, $\alpha$ 5).
Structural alignment with the cryo-EM EFC structure (PDB 9UZO) showed an overall RMSD of 1.176 Å, with notable flexibility in helices $\alpha$ 1, $\alpha$ 3, and $\alpha$ 5, suggesting these regions adapt during complex formation.

B. Functional Mapping of J5

Infectivity Assays:
- Mutations in helices $\alpha$ 1, $\alpha$ 2, $\alpha$ 5, and $\alpha$ 6 had minimal impact on infectivity (>75% of WT).
- Mutations in the P38YYCWY43 motif (located in $\alpha$ 4) and the disordered loop (residues 90–110) caused severe infectivity defects (reduced to ~26–33% of WT).
- Mutations in the Delta motif (residues 70–88) and helix $\alpha$ 3 (residues 22–40) resulted in moderate infectivity reductions (50–75%).
Fusion Activity:
- The P38Y39Y40W42Y435A mutant and the SW(90-110) mutant exhibited significantly reduced membrane fusion activity at low pH compared to WT, despite the presence of viral particles.
- TEM confirmed that these mutants formed normal intracellular mature virions (IMV), indicating the defects were specific to entry/fusion, not morphogenesis.

C. Distinct Roles in Assembly vs. Activation (Co-IP Analysis)

The study revealed a critical dichotomy in the function of the two key regions:

P38YYCWY43 Motif (Activation):
- The P38Y39Y40W42Y435A mutant retained the ability to assemble the full EFC. Co-IP showed that J5 still interacted with A16, G9, A28, and other components.
- Conclusion: This motif is dispensable for assembly but essential for fusion activation. It likely mediates conformational changes required for the fusion step rather than holding the complex together.
Residues 90–110 (Assembly):
- The SW(90-110) mutant failed to incorporate into the EFC. Co-IP showed that J5 could not pull down A16, G9, A28, H2, or L5.
- However, subcomplexes (A16/G9 and A28/H2) remained intact, indicating the defect was specific to J5's integration into the central trimer.
- Conclusion: The flexible region (90–110) is critical for stable incorporation of J5 into the EFC but is not the primary driver of the fusion trigger itself.

4. Significance and Implications

Mechanistic Insight: This study provides the first clear structural and functional dissection of J5, demonstrating that the VACV EFC utilizes distinct structural elements for assembly (residues 90–110) and activation (P38YYCWY43 motif).
Unique Fusion Mechanism: The findings reinforce that poxviruses employ a multi-protein fusion mechanism distinct from canonical Class I/II/III fusion proteins, where specific "activation" motifs can be separated from "assembly" scaffolds.
pH Sensitivity: The authors propose a model where the 90–110 region contains a pH-sensitive interaction network (involving residues like E107 and R109) that may destabilize upon acidification to facilitate the conformational rearrangements necessary for fusion.
Therapeutic Potential: Identifying the P38YYCWY43 motif as a "fusion switch" and the 90–110 region as an "assembly anchor" offers new targets for antiviral drugs. Inhibitors could be designed to either prevent EFC assembly or lock the complex in a pre-fusion state, blocking membrane fusion without necessarily preventing virion formation.

In summary, the paper elucidates that the J5 protein acts as a dual-function module: its C-terminal flexible loop secures it within the EFC, while its conserved N-terminal motif acts as the critical trigger for membrane fusion, a discovery that refines the understanding of poxvirus entry mechanisms.